Human Immunodeficiency Virus (HIV)

Andrew E. Auber1, Clifford Belden1

1 Brooke Army Medical Center, San Antonio, Texas
Publication Name:  Current Protocols in Magnetic Resonance Imaging
Unit Number:  Unit A4.3
DOI:  10.1002/0471142719.mia0403s02
Online Posting Date:  November, 2001
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library


Magnetic Resonance Imaging (MRI) for the evaluation of patients infected with human immunodeficiency virus (HIV), as with most other forms of intracranial inflammatory or infectious diseases, is a powerful though largely nonspecific diagnostic tool. For imaging of these complex patients with the varied and numerous pathologies they may harbor, the standard protocol is utilized to include gadolinium‐enhanced sequences. This unit presents optional imaging sequences, including magnetic resonance diffusion (dMRI), magnetic resonance perfusion (pMRI), and magnetic resonance spectroscopy (MRS), that can be employed should patient tolerance allow and if specific the clinical situation requires further clarification.

PDF or HTML at Wiley Online Library

Table of Contents

  • Basic Protocol 1: Imaging of HIV
  • Alternate Protocol 1: Special Situations
  • Commentary
  • Figures
  • Tables
PDF or HTML at Wiley Online Library


Basic Protocol 1: Imaging of HIV

  • Extravascular contrast agent (e.g., 0.1 mmol/kg patient body weight of gadolinium chelate from Mangevist, Omniscan, or Prohance)
  • Normal saline (0.9% NaCl) sterile
PDF or HTML at Wiley Online Library



Literature Cited

Literature Cited
   Chang, L., Miller, B.L., McBride, D., Cornford, M., Oropilla, G., Buchtal, S., Chiang, F., Aronow, H., and Ernst, T. 1995. Brain lesions in patients with AIDS: H‐1 MR spectroscopy. Radiology 197:525‐531.
   Donovan‐Post, M.J., Yiannoutsos, C., Simpson, D., Booss, J., Clifford, D.B., Cohen, B., McArthur, J.C., Hall, C.D., and the AIDS Clinical Trials Group, 243 Team. 1999. Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient survival. A.J.N.R. 20:1896‐1906.
   Ernst, T.M., Chang, L., Witt, M.D., Aronow, H.A., Cornford, M.E., Walot, I., and Goldberg, M.A. 1998. Cerebral toxoplasmosis and lymphoma in AIDS: Perfusion MR experience in 13 patients. Radiology 208:663‐669.
   Fauci, A.S. 1999. The AIDS epidemic: Considerations for the 21st century. N. Engl. J. Med. 341:1046‐1050.
   Harris, D.E. and Enterline, D.S. 1997. Fungal infections of the central nervous system. Neuroimaging Clin. N. Am. 7:187‐198.
   Pomper, M.G., Miller, T.J., Stone, J.H., Tidmore, W.C., and Hellmann, D.B. 1999. CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. A.J.N.R. 20:75‐85.
   Shah, S.S., Zimmerman, R.A., Rorke, L.B., and Vezina, L.G. 1996. Cerebrovascular complications of HIV in children. A.J.N.R. 17:1913‐1917.
   Shellock, F.G. 1996. Pocket Guide to MR Procedures and Metallic Objects. Lippincott‐Raven, Philadelphia.
   Taveras, J.M. and Pile‐Spellman, J. 1996. Inflammatory diseases. In Neuroradiology, 3rd edition pp. 259‐326. Williams and Wilkins, Baltimore.
   Walot, I., Miller, B.L., Chang, L., and Mehringer, C.M. 1996. Neuroimaging findings in patients with AIDS. Clin. Infect. Dis. 22:906‐919.
   Wong, J. and Quint, D.J. 1999. Imaging of central nervous system infections. Semin. Roentgenol. 34:123‐143.
Key Reference
   Walot et al., 1996. See above.
  Presents a directed and concise summary of the myriad imaging appearances encountered in this complex patient population.
PDF or HTML at Wiley Online Library